Navigation Links
Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
Date:2/9/2011

TARRYTOWN, N.Y., Feb. 9, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that it will webcast an investor briefing on Sunday, February 13 from 9 a.m. to 10:30 a.m. Eastern Time.  At the investor briefing, principal investigators from the VEGF Trap-Eye clinical studies will recap presentations from the Bascom Palmer Eye Institute's Angiogenesis, Exudation and Degeneration 2011 meeting being held in Miami, Florida on Saturday, February 12.  

The investigator presentations will provide additional data from the VIEW 1 and VIEW 2 Phase 3 trials in patients with the neovascular form of age-related macular degeneration (wet AMD), the COPERNICUS Phase 3 trial in macular edema due to central retinal vein occlusion (CRVO), and the DA VINCI Phase 2 trial in diabetic macular edema (DME).  Regeneron reported positive top-line results from all these trials in the fourth quarter of 2010.

"It's a privilege to be able to release this important collection of VEGF Trap-Eye data at the Bascom Palmer Eye Institute's Eighth Annual Angiogenesis Meeting," said  Philip J. Rosenfeld, M.D., Ph.D., Professor of Ophthalmology, University of Miami Miller School of Medicine and Course Co-Director of the Angiogenesis 2011 Meeting.  "In particular, the Phase 3 results in wet AMD suggest that the VEGF Trap-Eye has the potential to address an important unmet need of providing optimal vision gain while reducing the burden of intravitreal injections and office visits for patients and their caregivers."  

The webcast and slides may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page (http://investor.regeneron.com).  An archived version of the presentation will be available after the live webcast through M
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regeneron Announces Presentation at the ISI Annual Conference
2. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
3. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
4. Christine A. Poon Elected to Regeneron Board of Directors
5. Regeneron Announces Presentation at the 2010 Credit Suisse Annual Healthcare Conference
6. Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference
7. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
8. Regeneron Increases Size of Public Offering of Common Stock
9. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
10. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
11. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  Today, the National ... of the 2015 National Mobility Awareness Month Local Heroes ... Local Hero online entries that received 1.3 million votes. ... Chrysler , Toyota Mobility , and Valley ... BraunAbility and Vantage Mobility International (VMI) ...
(Date:6/30/2015)... , June 30, 2015 Today, UBM ... signed an agreement with Chengdu Tianyi Exhibition Co., Ltd. ... , which is to be held concurrently with CWMEE ... to UBM,s healthcare exhibition family, following MEDTEC China and ... exhibition market in west China. It,s also another concrete ...
(Date:6/30/2015)...  July 4 th is this weekend, a time ... and people behind it. To help honor our current nation,s ... USA Medical Card, a leading provider of free ... empower independence for our disabled military veterans, police, firemen, and ... their prescriptions. "Due to USA ...
Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2
... SAN DIEGO, and PARSIPPANY, N.J., Feb. 15, 2011 ... ), an emerging specialty pharmaceutical company, today announced ... its Phase 3 trial of EXPAREL™ (bupivacaine extended-release ... safety in wound healing and significantly improved efficacy ...
... 15, 2011 MIM Software Inc., a leading global ... MIM™ is available on the U.S. App Store. This ... the app had received 510(k) clearance for remote diagnostic ... the iPhone®, iPod touch®, and iPad®. (Photo: ...
Cached Medicine Technology:Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 2Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 3Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 4Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 5Mobile MIM, First FDA-Cleared Diagnostic Medical Imaging App, Now Available on the U.S. App Store 2Mobile MIM, First FDA-Cleared Diagnostic Medical Imaging App, Now Available on the U.S. App Store 3
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has ... first Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... The Trenton Health Team ACO draws on the collaborative structure of THT, bringing together ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to a recent report by the ... heroin-related deaths more than tripled in the same period—leading a majority of law enforcement ... Center , a leading Florida-based drug treatment facility, asserts that these heroin statistics point ...
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its ... and family member testimonials. Medicare rated the care center as a five-star location based ... video to give future patients a firsthand look at the facility’s satisfied residents. ...
(Date:6/30/2015)... ... June 30, 2015 , ... From the moment a ... wowed with the incredible care that they receive and the luxury in which they ... but now they are proud to offer the same experience, just better! , Their ...
(Date:6/30/2015)... ... 2015 , ... MJH Associates today welcomed Jim ... & Analytics , a consultative healthcare market research practice that is part of ... offers quantitative and qualitative, custom and multi-client primary market research services to support ...
Breaking Medicine News(10 mins):Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3
... Choices ( http://www.nhs.uk ), the,online ,front door, to ... to,help people make sense of the stories appearing ... headlines, on NHS Choices,( http://www.nhs.uk/News/Pages/NewsIndex.aspx ), is an ... The service explains the,facts behind newspaper headlines and ...
... Study finds spouses die sooner in unions where anger is ... the secret to a long marriage is communication, and new ... life. , A lengthy study of Midwestern couples finds that ... than the perennially resentful. The couples with the most unexpressed ...
... AT RECEPTION 5:30 PM WED., FEB. 13 AT MARRIOTT,ADDRESS ... WVAADC, LEGISLATIVE LEADERS, AND CRC HEALTH GROUP CEO ... Four-Star General,Barry McCaffrey (ret.), the former White House ... expert in the national media, will,spearhead a Feb. 13-14 ...
... a unique opportunity for ECNP-members to support young ... Research Grants for Young Scientists each year. Each ... 50,000. , The objective of the grant is ... young scientists in neuropsychopharmacology and/or closely related disciplines ...
... - Bradmer Pharmaceuticals Inc.,a biopharmaceutical company dedicated to ... that Dr. Alan M.,Ezrin, President and Chief Executive ... and panelist at the 10th Annual BIO CEO ... on the Company,s,preparations for the planned Phase III ...
... announced today that Michael Davis, a neuroscientist at Emory ... of the Edward M. Scolnick Prize in Neuroscience. The ... to recognize an individual who has made outstanding advances ... the Robert W. Woodruff Professor of Psychiatry and Behavioral ...
Cached Medicine News:Health News:Mutual Resentment in Marriage Can Be Deadly 2Health News:Mutual Resentment in Marriage Can Be Deadly 3Health News:4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, and Dr. Barry Karlin, Nation's #1 Drug Treatment Provider, to Spearhead Drug Treatment WVA Advocacy Day Feb 13-14; 142,000 Need, Don't Get Treatment in State 2Health News:Bradmer to present at the 10th Annual BIO CEO & Investor Conference 2Health News:MIT's McGovern Institute honors Emory neuroscientist for contributions to psychiatry 2
DAVINCI® performs all required steps primary tube sampling, reagent dispensing, microplate incubation, washing and optical reading....
... contains 266 amino acids and is variably N-glycosylated. ... estimates of between 43 and 56 kDa. Insulin-like ... with high affinity but do not bind insulin. ... characterized at this time, IGFBP-3 has been shown ...
... detection and semi-quantitation of ... antigen in serum as ... diagnosis of autoimmune disease. ... performed either manually or ...
Qualitative EIA for SS-A, SS-B, Sm, Sm/RNP plus Scl-70 and Jo-1...
Medicine Products: